exarafenib
kinnate biopharma
['melanoma', 'solid tumor', 'kin-2787', 'exarafenib', '$knte']
$knte ct032 - trials in progress: a global phase 1/1b clinical trial evaluating exarafenib (kin-2787), a highly selective pan-raf inhibitor, in adult patients with braf-altered solid tumors and nras mutant melanoma #aacr23 17.6% orr 
L/S biotech. PhD student @UniofOxford